Compositions comprising beta-adrenergic receptor antagonists and diuretics
作者： Pramod Kharwade , Indu Bhushan
DOI:
关键词: Immediate release 、 Inert 、 Adrenergic receptor 、 Metoprolol Succinate 、 Chromatography 、 Metoprolol 、 Materials science 、 Hydrochlorothiazide 、 Controlled release
摘要: Pharmaceutical compositions comprise beta-adrenergic receptor blocking agents for controlled release and diuretics immediate release. In an embodiment, a composition comprising metoprolol succinate is coated onto inert particles, the particles are further with polymer to provide of metoprolol. The coated, granulated, or mixed hydrochlorothiazide, then compressed into tablets, tablets hydrochlorothiazide.
google.co.uk 参考文章(7)
Sven Palmer, Michael Sidenqvist, Manufacturing process of metoprolol ,(1997)
Richard Aiena, Bhudev Sharma, Temple Okarter, Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases ,(2003)
Chih-Ming Chen, Xiu Xiu Cheng, Controlled release oral dosage form of beta-adrenergic blocking agents ,(2002)
Badal Kumar Sasmal, Mailatur Sivaraman Mohan, Billa Praveen Reddy, Vijay Dinanathji Nasare, Treatment and prevention of cardiovascular events ,(2004)
Tomas Norling, Jens Hansen, Lone Norgaard Jensen, Pharmaceutical multiple unit particulate formulation in the form of coated cores ,(1995)
Sjo, Lars-Erik D. Dahlinder, Mats O. Johansson, John A. Sandberg, Controlled release beads having glass or silicon dioxide core ,(1986)
Samuel Yuk, Avinash Nangia, Mongkol Sriwongjanya, Formulation and process for drug loaded cores ,(2003)